Literature DB >> 11004257

Treatment of persistent corneal epithelial defect with extended wear of a fluid-ventilated gas-permeable scleral contact lens.

P Rosenthal1, J M Cotter, J Baum.   

Abstract

PURPOSE: To report treatment of persistent corneal epithelial defects unresponsive to other therapies by extended wear of a fluid-ventilated gas-permeable scleral contact lens.
METHODS: In this retrospective study, 14 eyes of 13 consecutive patients referred for the treatment of persistent corneal epithelial defects that failed to heal with conventional therapies or developed epithelial defects after penetrating keratoplasty for persistent corneal epithelial defects were fitted with an extended-wear gas-permeable scleral lens. These included seven eyes of six patients with Stevens-Johnson syndrome and seven eyes of seven patients who did not have Stevens-Johnson syndrome. Twelve eyes had undergone recent penetrating keratoplasty. All 14 eyes were fitted with a gas-permeable scleral contact lens designed to avoid the intrusion of air bubbles under its optic. An antibiotic and corticosteroid were added to the lens fluid reservoir or instilled before each lens insertion in 12 of 14 eyes. The lenses were worn continuously except for brief periods of removal for purposes of cleaning, replacement of the lens fluid reservoir, and examination and photography of the cornea.
RESULTS: Five of the seven persistent corneal epithelial defects associated with Stevens-Johnson syndrome healed. The persistent corneal epithelial defects of four of these eyes re-epithelialized within 7 days, and a fifth healed in 27 days of gas-permeable scleral lens extended wear. A sixth persistent corneal epithelial defect that failed to heal initially re-epithelialized after a subsequent penetrating keratoplasty and gas-permeable scleral lens extended wear. The seventh eye healed after 3 days of gas-permeable scleral lens extended wear, but the persistent corneal epithelial defect subsequently recurred. Three of seven non-Stevens-Johnson syndrome persistent corneal epithelial defects re-epithelialized within 36 hours, 6 days, and 36 days, respectively. Of the six (six of 14) persistent corneal epithelial defects that failed to heal with a gas-permeable scleral lens extended wear, one subsequently healed after multiple amniotic membrane grafts. Microbial keratitis occurred in four eyes (four of 14) and graft failure in one eye, all of which required repeat penetrating keratoplasty.
CONCLUSION: Extended wear of an appropriately designed gas-permeable scleral contact lens was effective in promoting the healing of persistent corneal epithelial defects in some eyes that failed to heal after other therapeutic measures. Re-epithelialization appears to be aided by a combination of oxygenation, moisture, and protection of the fragile epithelium afforded by the scleral lens. However, microbial keratitis represents a significant risk.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11004257     DOI: 10.1016/s0002-9394(00)00379-2

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  15 in total

Review 1.  Graft failure: II. Ocular surface complications.

Authors:  Samar A Al-Swailem
Journal:  Int Ophthalmol       Date:  2008-06       Impact factor: 2.031

Review 2.  Dysfunctional tear syndrome: dry eye disease and associated tear film disorders - new strategies for diagnosis and treatment.

Authors:  Mark S Milner; Kenneth A Beckman; Jodi I Luchs; Quentin B Allen; Richard M Awdeh; John Berdahl; Thomas S Boland; Carlos Buznego; Joseph P Gira; Damien F Goldberg; David Goldman; Raj K Goyal; Mitchell A Jackson; James Katz; Terry Kim; Parag A Majmudar; Ranjan P Malhotra; Marguerite B McDonald; Rajesh K Rajpal; Tal Raviv; Sheri Rowen; Neda Shamie; Jonathan D Solomon; Karl Stonecipher; Shachar Tauber; William Trattler; Keith A Walter; George O Waring; Robert J Weinstock; William F Wiley; Elizabeth Yeu
Journal:  Curr Opin Ophthalmol       Date:  2017-01       Impact factor: 3.761

3.  Management strategies for persistent epithelial defects of the cornea.

Authors:  Lee R Katzman; Bennie H Jeng
Journal:  Saudi J Ophthalmol       Date:  2014-07-02

Review 4.  Contact Lens-induced Limbal Stem Cell Deficiency.

Authors:  Jennifer Rossen; Alec Amram; Behrad Milani; Dongwook Park; Jennifer Harthan; Charlotte Joslin; Timothy McMahon; Ali Djalilian
Journal:  Ocul Surf       Date:  2016-07-30       Impact factor: 5.033

5.  Scleral lenses for severe chronic GvHD-related keratoconjunctivitis sicca: a retrospective study by the SFGM-TC.

Authors:  L Magro; J Gauthier; M Richet; M Robin; S Nguyen; F Suarez; J-H Dalle; T Fagot; A Huynh; M-T Rubio; R Oumadely; S Vigouroux; N Milpied; A Delcampe; I Yakoub-Agha
Journal:  Bone Marrow Transplant       Date:  2017-02-20       Impact factor: 5.483

6.  Prosthetic Replacement of the Ocular Surface Ecosystem (PROSE) scleral lens for Salzmann's nodular degeneration.

Authors:  Gloria B Chiu; Dianne Bach; Christos Theophanous; Martin Heur
Journal:  Saudi J Ophthalmol       Date:  2014-06-18

7.  [Sterility of non-preserved autologous serum drops for treatment of persistent corneal epithelial defects].

Authors:  R Sauer; K Blüthner; B Seitz
Journal:  Ophthalmologe       Date:  2004-07       Impact factor: 1.059

8.  Diphtheroids as Corneal Pathogens in Chronic Ocular Surface Disease in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis.

Authors:  Swapna S Shanbhag; Grace Shih; Paulo J M Bispo; James Chodosh; Deborah S Jacobs; Hajirah N Saeed
Journal:  Cornea       Date:  2021-06-01       Impact factor: 3.152

Review 9.  Diagnostic procedures and management of dry eye.

Authors:  Snježana Kaštelan; Martina Tomić; Jasminka Salopek-Rabatić; Branko Novak
Journal:  Biomed Res Int       Date:  2013-08-19       Impact factor: 3.411

10.  Comparing the effects of two different contact lenses on corneal re-epithelialization after corneal collagen cross-linking.

Authors:  Yusuf Kocluk; Savas Cetinkaya; Emine Alyamac Sukgen; Murat Günay; Alper Mete
Journal:  Pak J Med Sci       Date:  2017 May-Jun       Impact factor: 1.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.